Hot Penny Stocks

Cannabis Penny Stocks

US-listed cannabis and marijuana penny stocks, priced $0.50 to $5, ranked by today's percentage change. Cultivators, MSOs (multi-state operators), edibles, REITs with cannabis tenants, and ancillary plays — everything tagged to the cannabis theme. Updated intraday.

Data as of 7/15/2026 1:40:35 AM · Intraday prices · 19 penny stocks in theme

#	Symbol	Company	Sector	Price	Day Chg	Volume
1	ARTL	Artelo Biosciences, Inc. Common Stock	Healthcare	$1.1610	+9.05%	243K
2	GRWG	GROW GENERATION CORP	Consumer Discretionary	$1.4450	+3.45%	247K
3	AFCG	Advanced Flower Capital Inc. Common Stock	Financials	$2.8750	+1.05%	62K
4	VFF	Village Farms International, Inc. Common Shares	Consumer Staples	$2.0650	+0.50%	635K
5	CRON	Cronos Group Inc. Common Share	Healthcare	$2.7580	0.00%	516K
6	ISPR	Ispire Technology Inc. Common Stock	Consumer Staples	$1.7350	0.00%	123K
7	SPRC	SciSparc Ltd. Ordinary Shares	Healthcare	$4.5850	0.00%	57K
8	INM	InMed Pharmaceuticals Inc. Common Shares	Healthcare	$1.5550	0.00%	49K
9	MIRA	MIRA Pharmaceuticals, Inc. Common Stock	Healthcare	$0.9190	0.00%	22K
10	INCR	Intercure Ltd. Ordinary Shares	Healthcare	$0.9840	0.00%	19K
11	GNLN	Greenlane Holdings, Inc. Class A Common Stock	Consumer Discretionary	$2.3700	0.00%	6K
12	XXII	22nd Century Group Inc.	Consumer Staples	$4.1650	0.00%	3K
13	CGC	Canopy Growth Corporation Common Shares	Healthcare	$0.9630	-0.17%	1.4M
14	ACB	Aurora Cannabis Inc. Common Shares	Healthcare	$2.6700	-0.19%	1.1M
15	OGI	Organigram Global Inc. Common Shares	Healthcare	$0.8930	-0.50%	698K
16	HITI	High Tide Inc. Common Shares	Consumer Discretionary	$2.1940	-0.69%	386K
17	SNDL	Sundial Growers Inc. Common Shares	Consumer Discretionary	$1.3050	-0.76%	903K
18	YCBD	cbdMD, Inc. Common Stock	Consumer Staples	$0.6710	-1.76%	195K
19	TLRY	Tilray Brands, Inc. Common Stock	Healthcare	$4.3790	-2.02%	3.2M

What Drives Cannabis Penny Stocks

Cannabis at the sub-$5 level is a uniquely policy-driven trade. Federal cannabis is still Schedule I in the US (as of mid-2026), but rescheduling discussions, state legalization progress, banking access (SAFE Banking Act), and DOJ enforcement signals all move the entire group simultaneously. A single news headline can lift or sink the whole sub-$5 cannabis universe in a session.

Catalysts to know: DEA rescheduling decisions, SAFE Banking Act movement, state ballot initiatives, 280E tax interpretations, FDA cannabidiol rulings.
Banking constraint: federal status means most cannabis companies still cannot use traditional banking. This shows up as cash inefficiency, expensive financing, and recurring dilution.
OTC dominance: many cannabis names are on OTC Pink or OTCQX rather than major exchanges — see OTC vs Nasdaq for the disclosure differences.
State patchwork: companies with footprints in mature legal states (CA, CO, MA, IL) trade differently than those focused on newly-legal states; revenue ramps are stop-start.
Brand vs. wholesale: branded edibles/flower plays earn premium multiples; wholesale cultivators trade like commodities.
M&A consolidation: larger MSOs periodically scoop up sub-$5 names; takeout premiums of 30-100% have happened repeatedly.